M.J. Kaashoek

1.6k citations

27 papers · 1.3k indexed · h-index 18

Epidemiology top 5%
Agronomy and Crop Science top 1%
Ecology, Evolution, Behavior and Systematics top 2%
Immunology top 10%
Genetics

Co-authors: J.T. van Oirschot F.A.M. Rijsewijk Jasper J. Quak A. L. J. Gielkens A. Moerman Mieke A. Maris-Veldhuis K. Weerdmeester F. A. C. van Engelenburg
Topics: Herpesvirus Infections and Treatments (24 papers)T-cell and Retrovirus Studies (17 papers)Vector-Borne Animal Diseases (12 papers)
Cited by: Agronomy and Crop Science Epidemiology Ecology, Evolution, Behavior and Systematics
Journals: Journal of Clinical Microbiology Journal of General Virology Vaccine
Partner nations: Netherlands Serbia Belgium

In The Last Decade

M.J. Kaashoek

27 papers receiving 1.2k citations

Peers

Countries citing papers authored by M.J. Kaashoek

Since Specialization

Citations

This map shows the geographic impact of M.J. Kaashoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J. Kaashoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J. Kaashoek more than expected).

Fields of papers citing papers by M.J. Kaashoek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J. Kaashoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J. Kaashoek. The network helps show where M.J. Kaashoek may publish in the future.

Co-authorship network of co-authors of M.J. Kaashoek

This figure shows the co-authorship network connecting the top 25 collaborators of M.J. Kaashoek. A scholar is included among the top collaborators of M.J. Kaashoek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J. Kaashoek. M.J. Kaashoek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Evaluation of the Efficacy of a Novel Subunit Vaccine in the Prevention of Cryptosporidium parvum-Caused Diarrhoea in Neonatal Calves 2025 ·Animals ·(unknown),(unknown),(unknown),(unknown),Sara Pel,(unknown),M.J. Kaashoek,Geert Vertenten,T. van Werven,(unknown),(unknown),(unknown)	3
2	Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement 2019 ·Biologicals ·(unknown),Marlies Halder,Marion F. Gruber,(unknown),Klaus Cußler,Gautam Sanyal,(unknown),(unknown),M.J. Kaashoek,Derek Litthauer,(unknown),(unknown),(unknown),Hongtao Jin,Joris Vandeputte,Troy Seidle,(unknown)	12
3	Epitopes on glycoprotein E and on the glycoprotein E/glycoprotein I complex of bovine herpesvirus 1 are expressed by all of 222 isolates and 11 vaccine strains 2000 ·Archives of Virology ·F.A.M. Rijsewijk,M.J. Kaashoek,Jan Langeveld,Mieke A. Maris-Veldhuis,Juana Magdalena,(unknown),R. H. Meloen,J.T. van Oirschot	11
4	Strains of bovine herpesvirus 1 that do not express an epitope on glycoprotein E in cell culture still induce antibodies that can be detected in a gE-blocking ELISA 1999 ·Veterinary Microbiology ·J.T. van Oirschot,M.J. Kaashoek,Mieke A. Maris-Veldhuis,F.A.M. Rijsewijk	9
5	An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field 1998 ·Vaccine ·(unknown),M.C.M. de Jong,P. Franken,K. Frankena,J. Joris Hage,M.J. Kaashoek,Mieke A. Maris-Veldhuis,J.P.T.M. Noordhuizen,Wim H. M. van der Poel,Joost J.C. Verhoeff,K. Weerdmeester,Gert Zimmer,J.T. van Oirschot	55
6	Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene 1998 ·Vaccine ·M.J. Kaashoek,F.A.M. Rijsewijk,Robin Ruuls,(unknown),E. Thiry,P.-P. Pastoret,J.T. van Oirschot	78
7	Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine 1997 ·Vaccine ·(unknown),M.J. Kaashoek,J.T. van Oirschot	54
8	An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle 1997 ·Journal of Virological Methods ·J.T. van Oirschot,M.J. Kaashoek,Mieke A. Maris-Veldhuis,K. Weerdmeester,F.A.M. Rijsewijk	74
9	Identification of epitopes on glycoprotein C of bovine herpesvirus 1 that allow differentiation between "IBR-like" and "IPV-like" strains 1997 ·Socio-Environmental Systems Modeling ·(unknown),M.J. Kaashoek,Jan Langeveld,Rob H. Meloen,(unknown),(unknown),Mieke A. Maris-Veldhuis,J.T. van Oirschot	1
10	Advances in the development and evaluation of bovine herpesvirus 1 vaccines 1996 ·Veterinary Microbiology ·J.T. van Oirschot,M.J. Kaashoek,F.A.M. Rijsewijk	67
11	The role of glycoproteins gC, gE, gI and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1 1996 ·Veterinary Microbiology ·Martine Denis,Emmanuel Hanon,Frans A.M. Rijsewijk,M.J. Kaashoek,J.T. van Oirschot,Étienne Thiry,Paul-Pierre Pastoret	11
12	Persistence of antibodies against bovine herpesvirus 1 and virus reactivation two to three years after infection 1996 ·Veterinary Microbiology ·M.J. Kaashoek,F.A.M. Rijsewijk,J.T. van Oirschot	48
13	Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine 1996 ·Veterinary Microbiology ·M.J. Kaashoek,J.T. van Oirschot	30
14	An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines 1996 ·Veterinary Microbiology ·(unknown),M.J. Kaashoek,(unknown),J.T. van Oirschot	55
15	Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants 1996 ·Veterinary Microbiology ·M.J. Kaashoek,F. A. C. van Engelenburg,A. Moerman,A. L. J. Gielkens,F.A.M. Rijsewijk,J.T. van Oirschot	44
16	The use of marker vaccines in eradication of herpesviruses 1996 ·Journal of Biotechnology ·J.T. van Oirschot,M.J. Kaashoek,F.A.M. Rijsewijk,J.A. Stegeman	79
17	An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation 1995 ·Vaccine ·M.J. Kaashoek	80
18	A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period 1995 ·Journal of General Virology ·F. A. C. van Engelenburg,M.J. Kaashoek,J.T. van Oirschot,F.A.M. Rijsewijk	43
19	Quantitative assessment of the specific CD4+ T lymphocyte proliferative response in bovine herpesvirus 1 immune cattle 1994 ·Veterinary Immunology and Immunopathology ·Martine Denis,M.J. Kaashoek,J.T. van Oirschot,P.P. Pastoret,Étienne Thiry	12
20	A glycoprotein E deletion mutant of bovine herpesvirus 1 is avirulent in calves 1994 ·Journal of General Virology ·F. A. C. van Engelenburg,M.J. Kaashoek,F.A.M. Rijsewijk,(unknown),A. Moerman,A. L. J. Gielkens,J.T. van Oirschot	81

About M.J. Kaashoek

M.J. Kaashoek is a scholar working on Immunology, Epidemiology and Agronomy and Crop Science, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (24 papers), T-cell and Retrovirus Studies (17 papers) and Vector-Borne Animal Diseases (12 papers). The work is most often cited by research in Agronomy and Crop Science (580 citations), Epidemiology (950 citations) and Ecology, Evolution, Behavior and Systematics (448 citations). M.J. Kaashoek has collaborated with scholars based in Netherlands, Serbia and Belgium. Frequent co-authors include J.T. van Oirschot, F.A.M. Rijsewijk, Jasper J. Quak, A. L. J. Gielkens, A. Moerman, Mieke A. Maris-Veldhuis, K. Weerdmeester, F. A. C. van Engelenburg, H. L. B. M. Klaasen and Mieke P. Vrijenhoek. Their work appears in journals such as Journal of Clinical Microbiology, Journal of General Virology and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact